Search
for
Sort by
Research 721–750 of 1000+
- A pilot study on the sexual side effects of finasteride as related to hand preference for men undergoing treatment of male pattern baldness
- Cataracts and strabismus associated with hand rearing using artificial milk formulas in Bengal tiger (<i>Panthera tigris spp tigris</i>) cubs
- Frozen Glove Therapy for Docetaxel-Induced Hand Problems May Not Fit All
- A comparative, open-label, randomised study; evaluating efficacy of a hand-held device using a combination of vibration and cold, versus only vibration; in reducing the pain sensation of multiple local anaesthesia injections during hair transplant
- Clear cell variant of eccrine porocarcinoma of the hand: A case report
- Effects of a new mild shampoo for preventing hair loss in Asian by a simple hand-held phototrichogram technique
- Single-handed vampire facial: Combining microneedling with platelet-rich plasma for single-hand use
- Anti-BPH lignans from <i>Urtica triangularis</i> subsp. <i>pinnatifida</i> (Hand.-Mazz.) C.J.Chen
- Measuring the Epilation Force Over the Frontal and Occipital Region in Cases of Female Pattern Hair Loss Using Hand Held Trichotilometer
- Quantitative Analysis of the Characteristics between Normal Controls and Androgenetic Alopecia in Korean Using the Simple Hand-held Phototrichogram System
- Cutaneous toxicities of cancer therapy
- Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer
- Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer
- Clinical development and management of adverse events associated with FGFR inhibitors
- Cutaneous Reactions to Chemotherapeutic Agents
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®)
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Non-Rash Skin Toxicities Associated with Novel Targeted Therapies
- Innovative Uses for Zinc in Dermatology
- Finasteride adverse effects in subjects with androgenic alopecia: A possible therapeutic approach according to the lateralization process of the brain
- Dermoscopic evaluation of skin in healthy cats
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Skin toxicity of anti‐cancer therapy
- Public interest in dermatologic symptoms, conditions, treatments, and procedures during the COVID‐19 pandemic: Insights from Google Trends
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- Disinfection, sterilization and operation theater guidelines for dermatosurgical practitioners in India